Trial intelligence / Profile preview

Melatonin add-on to antiepileptic drugs in seizure patients

IRCT20101209005352N4Phase 3Completed

Sponsor
Zanjan University of Medical Sciences
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of melatonin in seizure disorder, sponsored by Zanjan University of Medical Sciences. Started Oct 2017; status: completed.

02

Drugs

melatonin
03

Conditions

seizure disorder

Beyond the preview

Go deeper on IRCT20101209005352N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20101209005352N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call